Oncogene - Table of Contents alert Volume 33 Issue 35

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 33, Issue 35 (August 2014) In this issue Review Original Articles Short Communication Retraction Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Your submitted manuscript needs to make a good first impression. Nature Publishing Group Language Editing service focuses on improving your written English. So it's your results that stand out, not your grammar. Save 10% by entering code LE_NAT14. Upload your manuscript today    Review Top MDM2’s social network R Fåhraeus and V Olivares-Illana Oncogene 2014 33: 4365-4376; advance online publication, October 7, 2013; 10.1038/onc.2013.410 Abstract | Full Text Original Articles Top Cell competition may function either as tumour-suppressing or as tumour-stimulating factor in Drosophila L Ballesteros-Arias, V Saavedra and G Morata Oncogene 2014 33: 4377-4384; advance online publication, October 7, 2013; 10.1038/onc.2013.407 Abstract | Full Text Phosphorylation of paxillin confers cisplatin resistance in non-small cell lung cancer via activating ERK-mediated Bcl-2 expression D-W Wu, T-C Wu, J-Y Wu, Y-W Cheng, Y-C Chen, M-C Lee, C-Y Chen and H Lee Oncogene 2014 33: 4385-4395; advance online publication, October 7, 2013; 10.1038/onc.2013.389 Abstract | Full Text Interleukin 6 downregulates p53 expression and activity by stimulating ribosome biogenesis: a new pathway connecting inflammation to cancer OPEN E Brighenti, C Calabrese, G Liguori, F A Giannone, D Trerè, L Montanaro and M Derenzini Oncogene 2014 33: 4396-4406; advance online publication, February 17, 2014; 10.1038/onc.2014.1 Abstract | Full Text Wig-1 regulates cell cycle arrest and cell death through the p53 targets FAS and 14-3-3σ OPEN C Bersani, L-D Xu, A Vilborg, W-O Lui and K G Wiman Oncogene 2014 33: 4407-4417; advance online publication, January 27, 2014; 10.1038/onc.2013.594 Abstract | Full Text Oncogenic RIT1 mutations in lung adenocarcinoma OPEN A H Berger, M Imielinski, F Duke, J Wala, N Kaplan, G-X Shi, D A Andres and M Meyerson Oncogene 2014 33: 4418-4423; advance online publication, January 27, 2014; 10.1038/onc.2013.581 Abstract | Full Text FOXO3a loss is a frequent early event in high-grade pelvic serous carcinogenesis K Levanon, S Sapoznik, K Bahar-Shany, H Brand, R Shapira-Frommer, J Korach, M S Hirsch, M H Roh, A Miron, J F Liu, N Vena, A H Ligon, S Fotheringham, D Bailey, R J Flavin, M J Birrer and R I Drapkin Oncogene 2014 33: 4424-4432; advance online publication, September 30, 2013; 10.1038/onc.2013.394 Abstract | Full Text Inhibition of monocarboxylate transporter-4 depletes stem-like glioblastoma cells and inhibits HIF transcriptional response in a lactate-independent manner K S Lim, K J Lim, A C Price, B A Orr, C G Eberhart and E E Bar Oncogene 2014 33: 4433-4441; advance online publication, September 30, 2013; 10.1038/onc.2013.390 Abstract | Full Text Short Communication Top The MYB proto-oncogene suppresses monocytic differentiation of acute myeloid leukemia cells via transcriptional activation of its target gene GFI1 L Zhao, P Ye and T J Gonda Oncogene 2014 33: 4442-4449; advance online publication, October 14, 2013; 10.1038/onc.2013.419 Abstract | Full Text Retraction Top IL-6 secreted by cancer-associated fibroblasts induces tamoxifen resistance in luminal breast cancer X Sun, Y Mao, J Wang, L Zu, M Hao, G Cheng, Q Qu, D Cui, E T Keller, X Chen, K Shen and J Wang Oncogene 2014 33: 4450; 10.1038/onc.2014.224 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.